US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist
  • 48.750
  • +0.270+0.56%
Close May 28 16:00 ET
  • 48.750
  • 0.0000.00%
Post 16:01 ET
1.76BMarket Cap-9466P/E (TTM)

Keros Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Keros Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

83.00K

0.00%
EPS(YoY)

-1.21

+3.97%
Analyst Rating

Strong Buy

May 28, 2024

Keros Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q183.000K / 0.000--
--2023/Q4143.000K / 0.000--
--2023/Q310.000 / 0.000--
--2023/Q20.000 / 144.440K--
--2023/Q10.000 / 216.670K--
--2022/Q40.000 / 857.140K--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q183.000K / 0.000--
--2023/Q4143.000K / 0.000--
--2023/Q310.000 / 0.000--
--2023/Q20.000 / 144.440K--
--2023/Q10.000 / 216.670K--
--2022/Q40.000 / 857.140K--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Keros Therapeutics Earnings Reports

  • Keros Therapeutics | 10-Q: Quarterly report

    May 8 07:08

  • Keros Therapeutics | 10-K: Annual report

    Feb 28 21:27

  • Keros Therapeutics: Q3 2023 Earnings Report

    Nov 6, 2023 07:06

  • Keros Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 7, 2023 07:04

    • Read more

    Analysis

    Analyst Rating

    Updated: May 28, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg